Molecular recognition of RNA: Challenges for modelling interactions and plasticity

Journal of Molecular Recognition

Volumn 23, Issue 2, 2010, Pages 220-231

  Fulle, Simone ^a   Gohlke, Holger ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

A site; Continuum solvent; Docking; Elastic network model; MM PBSA; Molecular dynamics simulations; Ribosome

Indexed keywords

LIGAND; PROTEIN; RNA; WATER;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG DESIGN; METABOLISM; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN CONFORMATION; SMALL RIBOSOMAL SUBUNIT; THERMODYNAMICS;

DRUG DESIGN; LIGANDS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEINS; RIBOSOME SUBUNITS, SMALL, BACTERIAL; RNA; THERMODYNAMICS; WATER;

BACTERIA (MICROORGANISMS);

EID: 76649139475     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.1000     Document Type: Article

References (158)

1. Ahmed A, Gohlke H. 2006. Multiscale modeling of macromolecular conformational changes combining concepts from rigidity and elastic network theory. Proteins 63: 1038-1051.
2. Ahmed A, Kazemi S, Gohlke H. 2007. Protein flexibility and mobility in structure-based drug design. Front. Drug Des. Discov. 3: 455-476.
3. Al-Hashimi HM. 2005. Dynamics-based amplification of RNA function and its characterization by using NMR spectroscopy. ChemBioChem 6: 1506-1519.
4. Al-Hashimi HM, Gosser Y, Gorin A, Hu W, Majumdar A, Patel DJ. 2002. Concerted motions in HIV-1 TAR RNA may allow access to bound state conformations: RNA dynamics from NMR residual dipolar couplings. J. Mol. Biol. 315: 95-102.
5. Al-Hashimi HM, Pitt SW, Majumdar A, Xu W, Patel DJ. 2003. Mg2{thorn}-induced variations in the conformation and dynamics of HIV-1 TAR RNA probed using NMR residual dipolar couplings. J. Mol. Biol. 329: 867-873.
6. Al-Hashimi H, Walter N. 2008. RNA dynamics: it is about time. Curr. Opin. Struct. Biol. 18: 321-329.
7. Atilgan AR, Durell SR, Jernigan RL, Demirel MC, Keskin O, Bahar I. 2001. Anisotropy of fluctuation dynamics of proteins with an elastic net-work model. Biophys. J. 80: 505-515.
8. Auffinger P, Bielecki L, Westhof E. 2003. The Mg2{thorn} binding sites of the 5S rRNA loop E motif as investigated by molecular dynamics simulations. Chem. Biol. 10: 551-561.
9. Auffinger P, Hashem Y. 2007. Nucleic acid solvation: froms outside to insight. Curr. Opin. Struct. Biol. 17: 325-333.
10. Auffinger P, Westhof E. 2000. Water and ion binding around RNA and DNA (C,G) oligomers. J. Mol. Biol. 300: 1113-1131.
11. Babin V, Baucom J, Darden TA, Sagui C. 2006. Molecular dynamics simulations of DNA with polarizable force fields: convergence of an ideal B-DNA structure to the crystallographic structure. J. Phys. Chem. B 110: 11571-11581.
12. Bahar I, Atilgan A, Erman B. 1997. Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. Fold. Des. 2: 173-181.
13. Bahar I, Rader AJ. 2005. Coarse-grained normal mode analysis in structural biology. Curr. Opin. Struct. Biol. 15: 586-592.
14. Banavali NK, Roux B. 2002. Atomic radii for continuum electrostatics calculations on nucleic acids. J. Phys. Chem. B 106: 11026-11035.
15. Barbault F, Zhang LR, Zhang LH, Fan BT. 2006. Parametrization of a specific free energy function for automated docking against RNA targets using neural networks. Chemom. Intell. Lab. Syst. 82: 269-275.
16. Blount K, Breaker R. 2006. Riboswitches as antibacterial drug targets. Nat. Biotechnol. 24: 1558-1564.
17. Bomble Y, Case D. 2008. Multiscale modeling of nucleic acids: insights into DNA flexibility. Biopolymers 89: 722-731.
18. Brooks B, Karplus M. 1983. Harmonic dynamics of proteins: normal modes and fluctuations in bovine pancreatic trypsin inhibitor. Proc. Natl Acad. Sci. U.S.A. 80: 6571-6575.
19. Butler MS, Buss AD. 2006. Natural products-the future scaffolds for novel antibiotics? Biochem. Pharmacol. 71: 919-929.
20. Carlson C, Stephens O, Beal P. 2003. Recognition of double-stranded RNA by proteins and small molecules. Biopolymers 70: 86-102.
21. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. 2000. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407: 340-348.
22. Casianonegroni A, Sun X, Al-Hashimi HM. 2007. Probing Na({thorn})-induced changes in the HIV-1 TAR conformational dynamics using NMR residual dipolar couplings: new insights into the role of counterions and electrostatic interactions in adaptive recognition. Biochemistry 46: 6525-6535.
23. Cavasotto CN, Abagyan RA. 2004. Protein flexibility in ligand docking and virtual screening to protein kinases. J. Mol. Biol. 337: 209-225.
24. Cavasotto CN, Kovacs JA, Abagyan RA. 2005. Representing receptor flexibility in ligand docking through relevant normal modes. J. Am. Chem. Soc. 127: 9632-9640.
25. Cheatham TE. 2004. Simulation and modeling of nucleic acid structure, dynamics and interactions. Curr. Opin. Struct. Biol. 14: 360-367.
26. Cheatham TE, Cieplak P, Kollman PA. 1999. A modified version of the Cornell et al. force field with improved sugar pucker phases and helical repeat. J. Biomol. Struct. Dyn. 16: 845-862.
27. Cheatham TE, Miller JL, Fox T, Darden TA, Kollman PA. 1995. Molecular dynamics simulations on solvated biomolecular systems: the Particle Mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins. J. Amer. Chem. Soc. 117: 4193-4194.
28. Chen Q, Shafer RH, Kuntz ID. 1997. Structure-based discovery of ligands targeted to the RNA double helix. Biochemistry 36: 11402-11407.
29. Cieplak P, Cornell WD, Bayly C, Kollman PA. 1995. Application of the multimolecule and multiconformational RESP methodology to bio-polymers -charge derivation for DNA, RNA and proteins. J. Comput. Chem. 16: 1357-1377.
30. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA. 1995. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117: 5179-5197.
31. Das C, Frankel A. 2003. Sequence and structure space of RNA-binding peptides. Biopolymers 70: 80-85.
32. Detering C, Varani G. 2004. Validation of automated docking programs for docking and database screening against RNA drug targets. J. Med. Chem. 47: 4188-4201.
33. Draper DE. 2004. A guide to ions and RNA structure. RNA 3: 335-343.
34. Durand P, Trinquier G, Sanejouand YH. 1994. New approach for determining low-frequency normal-modes in macromolecules. Biopolymers 34: 759-771.
35. Eyal E, Yang L-W, Bahar I. 2006. Anisotropic network model: systematic evaluation and a new web interface. Bioinformatics 22: 2619-2627.
36. Ferner J, Villa A, Duchardt E, Widjajakusuma E, Wohnert J, Stock G, Schwalbe H. 2008. NMR and MD studies of the temperature-dependent dynamics of RNA YNMG-tetraloops. Nucleic Acid. Res. 36: 1928-1940.
37. Filikov AV, Mohan V, Vickers TA, Griffey RH, Cook PD, Abagyan RA, James TL. 2000. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR. J. Comput. Aid. Mol. Des. 14: 593-610.
38. Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R. 2004. A structure-based strategy to identify new molecular scaffolds target-ing the bacterial ribosomal A-site. Bioorg. Med. Chem. 12: 935-947.
39. Foloppe N, MacKerell AD. 2000. All-atom empirical force field for nucleic acids: I. Parameter optimization based on small molecule and con-densed phase macromolecular target data. J. Comput. Chem. 21: 86-104.
40. Foloppe N, Matassova N, Aboul-Ela F. 2006. Towards the discovery of drug-like RNA ligands? Drug Disc. Today 11: 1019-1027.
41. Fourmy D, Yoshizawa S, Puglisi JD. 1998. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J. Mol. Biol. 277: 333-345.
42. Franceschi F, Duffy E. 2006. Structure-based drug design meets the ribosome. Special Issue on Antibacterials 71: 1016-1025.
43. Fulle S, Gohlke H. 2008. Analysing the flexibility of RNA structures by constraint counting. Biophys. J. 94: 4202-4219.
44. Fulle S, Gohlke H. 2009a. Statics of the ribosomal exit tunnel: implications for co-translational peptide folding, elongation regulation, and anti-biotics binding. J. Mol. Biol. 387: 502-517.
45. Fulle S, Gohlke H. 2009b. Constraint counting on RNA structures: linking flexibility and function. Methods 49: 181-188.
46. Gallego J, Varani G. 2001. Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges. Acc. Chem. Res. 34: 836-843.
47. Garcia RG, Ferrer E, Macias MJ, Eritja R, Orozco M. 1999. Theoretical calculations, synthesis and base pairing properties of oligonucleo-tides containing 8-amino-2'-deoxyadenosine. Nucleic Acids Res. 27: 1991-1998.
48. Getz M, Sun X, Casiano-Negroni A, Zhang Q, Al-Hashimi HM. 2007. NMR studies of RNA dynamics and structural plasticity using NMR residual dipolar couplings. Biopolymers 86: 384-402.
49. Giudice E, Lavery R. 2002. Simulations of nucleic acids and their com-plexes. Acc. Chem. Res. 35: 350-357.
50. Go N, Noguti T, Nishikawa T. 1983. Dynamics of a small globular protein in terms of low-frequency vibrational modes. Proc. Natl Acad. Sci. U.S.A. 80: 3696-3700.
51. Gohlke H, Hendlich M, Klebe G. 2000. Knowledge-based scoring function to predict protein-ligand interactions. J. Mol. Biol. 295: 337-356.
52. Gohlke H, Klebe G. 2002. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. Angew. Chem. Int. Ed. 41: 2645-2676.
53. Gohlke H, Kiel C, Case DA. 2003. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J. Mol. Biol. 330: 891-913.
54. Gohlke H, Thorpe MF. 2006. A natural coarse graining for simulating large biomolecular motion. Biophys. J. 91: 2115-2120.
55. Gouda H, Kuntz ID, Case DA, Kollman PA. 2003. Free energy calculations for theophylline binding to an RNA aptamer: MM-PBSA and comparison of thermodynamic integration methods. Biopolymers 68: 16-34.
56. Guilbert C, James T. 2008. Docking to RNA via root-mean-square-deviation-driven energy minimization with flexible ligands and flexible targets. J. Chem. Inf. Mod. 48: 1257-1268.
57. Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF, Liu M, Vakulenko SB, Chow CS, Mobashery S. 2002. Design of novel antibiotics that bind to the ribosomal acyltransfer site. J. Am. Chem. Soc. 124: 3229-3237.
58. Hansen J, Ippolito J, Ban N, Nissen P, Moore P, Steitz T. 2002. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell 10: 117-128.
59. Hashem Y, Auffinger P. 2009. A short guide for molecular dynamics simulations of RNA systems. Methods 47: 187-197.
60. Hermann T. 2002. Rational ligand design for RNA: the role of static structure and conformational flexibility in target recognition. Biochimie 84: 869-875.
61. Hermann T. 2003. Chemical and functional diversity of small molecule ligands for RNA. Biopolymers 70: 4-18.
62. Hermann T, Westhof E. 1998. RNA as a drug target: chemical, modelling, and evolutionary tools. Curr. Opin. Biotechnol. 9: 66-73.
63. Hermann T, Westhof E. 1999. Docking of cationic antibiotics to negatively charged pockets in RNA folds. J. Med. Chem. 42: 1250-1261.
64. Hespenheide BM, Jacobs DJ, Thorpe MF. 2004. Structural rigidity in the capsid assembly of cowpea chlorotic mottle virus. J. Phys.: Condens. Matter 16: 5055-5064.
65. Huang SY, Zou XQ. 2007. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Proteins 66: 399-421.
66. Ippolito JA, Kanyo ZF, Wang D, Franceschi FJ, Moore PB, Steitz TA, Duffy EM. 2008. Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J. Med. Chem. 51: 3353-3356.
67. Ippolito JA, Steitz TA. 1998. A 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation. Proc. Natl Acad. Sci. U.S.A. 95: 9819-9824.
68. Jorgensen W, Chandrasekhar J, Madura J, Impey R, Klein M. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79: 926-935.
69. Kang XS, Shafer RH, Kuntz ID. 2004. Calculation of ligand-nucleic acid binding free energies with the generalized-born model in DOCK. Biopolymers 73: 192-204.
70. Kazemi S, Kruger DM, Sirockin F, Gohlke H. 2009. Elastic potential grids: accurate and efficient representation of intermolecular interactions for fully flexible docking. ChemMedChem 4: 1264-1268.
71. Kolk MH, van der Graaf M, Wijmenga SS, Pleij CW, Heus HA, Hilbers CW. 1998. NMR structure of a classical pseudoknot: interplay of single-and double-stranded RNA. Science 280: 434-438.
72. Kopitz H, Zivkovic A, Engels JW, Gohlke H. 2008. Determinants of the unexpected stability of RNA fluorobenzene self pairs. ChemBioChem 9: 2619-2622.
73. Kormos BL, Benitex Y, Baranger AM, Beveridge DL. 2007. Affinity and specificity of protein U1A-RNA complex formation based on an additive component free energy model. J. Mol. Biol. 371: 1405-1419.
74. Kurkcuoglu O, Kurkcuoglu Z, Doruker P, Jernigan RL. 2008. Collective dynamics of the ribosomal tunnel revealed by elastic network modeling. Proteins 75: 837-845.
75. Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, Thomas V, Rizzo RC, Case DA, James TL, Kuntz ID. 2009. DOC 6: combining techniques to model RNA-small molecul complexes. RNA 15: 1219-1230.
76. Leclerc F, Cedergren R. 1998. Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex. J. Med. Chem. 41: 175-182.
77. Leclerc F, Karplus M. 1999. MCSS-based predictions of RNA binding sites. Theor. Chem. Acc. 101: 131-137.
78. Leulliot N, Varani G. 2001. Current topics in RNA-protein recognition: control of specificity and biological function through induced fit and conformational capture. Biochemistry 40: 7947-7956.
79. Li GH, Cui Q. 2002. A coarse-grained normal mode approach for macro-molecules: an efficient implementation and application to Ca2{thorn}-ATPase. Biophys. J. 83: 2457-2474.
80. Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL. 2002. Structure-based computational database screening, in vitro assay, and NMR assess-ment of compounds that target TAR RNA. Chem. Biol. 9: 185-193.
81. Lustig B, Bahar I, Jernigan RL. 1998. RNA bulge entropies in the unbound state correlate with peptide binding strengths for HIV-1 and BIV TAR RNA because of improved conformational access. Nucleic Acids Res. 26: 5212-5217.
82. Ma C, Baker N, Joseph S, McCammon J. 2002. Binding of aminoglycoside antibiotics to the small ribosomal subunit: a continuum electrostatics investigation. J. Am. Chem. Soc. 124: 1438-1442.
83. Mackerell AD, Feig M, Brooks CL. 2004. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distri-butions in molecular dynamics simulations. J. Comput. Chem. 25: 1400-1415.
84. MacKerell AD, Nilsson L. 2008. Molecular dynamics simulations of nucleic acid-protein complexes. Curr. Opin. Struct. Biol. 18: 194-199.
85. McDowell ES, Spackoá Na, Sponer J, Walter N. 2007. Molecular dynamics simulations of RNA: an in silico single molecule approach. Biopolymers 85: 169-184.
86. Meroueh SO, Mobashery S. 2007. Conformational transition in the aminoacyl t-RNA site of the bacterial ribosome both in the presence and absence of an aminoglycoside antibiotic. Chem. Biol. Drug Des. 69: 291-297.
87. Micura R, Hobartner C. 2003. On secondary structure rearrangements and equilibria of small RNAs. ChemBioChem 4: 984-990.
88. Misra VK, Draper DE. 2002. The linkage between magnesium binding and RNA folding. J. Mol. Biol. 317: 507-521.
89. Moitessier N, Westhof E, Hanessian S. 2006. Docking of aminoglycosides to hydrated and flexible RNA. J. Med. Chem. 49: 1023-1033.
90. Morley SD, Afshar M. 2004. Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock. J. Comput. Aid. Mol. Des. 18: 189-208.
91. Mu Y, Stock G. 2006. Conformational dynamics of RNA-peptide binding: a molecular dynamics simulation study. Biophys. J. 90: 391-399.
92. Murray J, Meroueh S, Russell R, Lentzen G, Haddad J, Mobashery S. 2006. Interactions of designer antibiotics and the bacterial ribosomal aminoacyl-tRNA site. Chem. Biol. 13: 129-138.
93. Nabuurs SB, Wagener M, De Vlieg J. 2007. A flexible approach to induced fit docking. J. Med. Chem. 50: 6507-6518.
94. Nifosi R, Reyes CM, Kollman PA. 2000. Molecular dynamics studies of the HIV-1 TAR and its complex with argininamide. Nucleic Acids Res. 28: 4944-4955.
95. Ogle JM, Brodersen DE, Clemons WM, Tarry MJ, Carter AP, Ramakrishnan V. 2001. Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292: 897-902.
96. Orozco M, Luque FJ., 2000. Theoretical methods for the description of the solvent effect in biomolecular systems. Chem. Rev. 100: 4187-4225.
97. Orozco M, Noy A, Perez A. 2008. Recent advances in the study of nucleic acid flexibility by molecular dynamics. Curr. Opin. Struct. Biol. 18: 185-193.
98. Orozco M, Perez A, Noy A, Luque FJ., 2003. Theoretical methods for the simulation of nucleic acids. Chem. Soc. Rev. 32: 350-364.
99. Perez A, Luque FJ, Orozco M. 2007a. Dynamics of B-DNA on the micro-second time scale. J. Am. Chem. Soc. 129: 14739-14745.
100. Perez A, Marchan I, Svozil D, Sponer J, Cheatham T, Laughton C, Orozco M. 2007b. Refinement of the AMBER force field for nucleic acids: improving the description of a/g conformers. Biophys. J. 92: 3817-3829.
101. Pfeffer P, Gohlke H. 2007. DrugScoreRNA -knowledge-based scoring function to predict RNA-ligand interactions. J. Chem. Inf. Mod. 47: 1868-1876.
102. Ponder JW, Case DA. 2003. Force fields for protein simulations: Adv. Protein Chem. 66: 27-85.
103. Puglisi JD, Tan R, Calnan BJ, Frankel AD, Williamson JR. 1992. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science 257: 76-80.
104. Pyetan E, Baram D, Auerbach-Nevo T, Yonath A. 2007. Chemical parameters influencing fine-tuning in the binding of macrolide antibiotics to the ribosomal tunnel. Pure Appl. Chem. 79: 955-968.
105. Réblová K, Lankaš F, Rázga F, Krasovska MV, Koča J, Šponer J. 2006. Structure, dynamics, and elasticity of free 16S rRNA helix 44 studied by molecular dynamics simulations. Biopolymers 82: 504-520.
106. Reyes CM, Kollman PA. 2000a. Structure and thermodynamics of RNA-protein binding: using molecular dynamics and free energy analyses to calculate the free energies of binding and conformational change. J. Mol. Biol. 297: 1145-1158.
107. Reyes CM, Kollman PA. 2000b. Investigating the binding specificity of U1A-RNA by computational mutagenesis. J. Mol. Biol. 295: 1-6.
108. Reyes CM, Nifosi R, Frankel AD, Kollman PA. 2001. Molecular dynamics and binding specificity analysis of the bovine immunodeficiency virus BIV Tat-TAR complex. Biophys. J. 80: 2833-2842.
109. Rizzo RC, Aynechi T, Case DA, Kuntz ID. 2006. Estimation of absolute free energies of hydration using continuum methods: accuracy of partial, charge models and optimization of nonpolar contributions. J. Chem. Theor. Comput. 2: 128-139.
110. Russell RJ, Murray JB, Lentzen G, Haddad J, Mobashery S. 2003. The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography. J. Am. Chem. Soc. 125: 3410-3411.
111. Schluenzen F, Tocilj A, Zarivach R, Harms J, Gluehmann M, Janell D, Bashan A, Bartels H, Agmon I, Franceschi F, Yonath A. 2000. Structure of functionally activated small ribosomal subunit at 3.3 angstrom resolution. Cell 102: 615-623.
112. Schluenzen F, Harms JM, Franceschi F, Hansen HA, Bartels H, Zarivach R, Yonath A. 2003. Structural basis for the antibiotic activity of ketolides and azalides. Structure 11: 329-338.
113. Schluenzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413: 814-821.
114. Schwalbe H, Buck J, Fürtig B, Noeske J, Wöhnert J. 2007. Structures of RNA switches: insight into molecular recognition and tertiary structure. Angew. Chem. Int. Ed. 46: 1212-1219.
115. Shandrick S, Zhao Q, Han Q, Ayida BK, Takahashi M, Winters GC, Simonsen KB, Vourloumis D, Hermann T. 2004. Monitoring molecular recognition of the ribosomal decoding site. Angew. Chem. Int. Ed. 43: 3177-3182.
116. Skripkin E, McConnell TS, Devito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F. 2008. Rx-01: a new family of oxazolidinones that overcomes ribosomal-based linezolid resistance. Antimicrob. Agents Chemother. 52: 3550-3557.
117. Sousa SF, Fernandes PA, Ramos MJ. 2006. Protein-ligand docking: current status and future challenges. Proteins 65: 15-26.
118. Spackova N, Cheatham TE, Ryjacek F, Lankas F, van Meervelt L, Hobza P, Sponer J. 2003. Molecular dynamics simulations and thermodynamics analysis of DNA-drug complexes. Minor groove binding between 4' ',6-diamidino-2-phenylindole and DNA duplexes in solution. J. Am. Chem. Soc. 125: 1759-1769.
119. Sponer J, Burda JV, Sabat M, Leszczynski J, Hobza P. 1998. Interaction between the guanine-cytosine Watson-Crick DNA base pair and hydrated group IIa (Mg2+, Ca2+, Sr2+, Ba2+) and group IIb (Zn2+, Cd2+, Hg2+) metal cations. J. Phys. Chem. A 102: 5951-5957.
120. Sponer J, Jurecka P, Marchan I, Luque FJ, Orozco M, Hobza P. 2006. Nature of base stacking: reference quantum-chemical stacking energies in ten unique B-DNA base-pair steps. Chemistry 12: 2854-2865.
121. Sponer JE, Spackova N, Leszczynski J, Sponer J. 2005. Principles of RNA base pairing: structures and energies of the trans Watson-Crick/sugar edge base pairs. J. Phys. Chem. B 109: 11399-11410.
122. Srinivasan J, Cheatham TE, Cieplak P, Kollman PA, Case DA. 1998. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate - DNA helices. J. Am. Chem. Soc. 120: 9401-9409.
123. Srinivasan J, Leclerc F, Xu W, Ellington AD, Cedergren R. 1996. A docking and modelling strategy for peptide-RNA complexes: applications to BIV Tat-TAR and HIV Rev-RBE. Fold Des. 1: 463-472.
124. Still WC, Tempczyk A, Hawley RC, Hendrickson T. 1990. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 112: 6127-6129.
125. Suess B, Weigand JE. 2008. Engineered riboswitches: overview, problems and trends. RNA Biology 5: 24-29.
126. Sutcliffe J. 2005. Improving on nature: antibiotics that target the ribosome. Curr. Opin. Microbiol. 8: 534-542.
127. Tama F, Gadea FX, Marques O, Sanejouand YH. 2000. Building-block approach for determining low-frequency normal modes of macromolecules. Proteins 41: 1-7.
128. Tama F, Sanejouand YH. 2001. Conformational change of proteins arising from normal mode calculations. Protein Eng. 14: 1-6.
129. Tama F, Valle M, Frank J, Brooks CL. 2003. Dynamic reorganization of the functionally active ribosome explored by normal mode analysis and cryo-electron microscopy. Proc. Natl. Acad. Sci. U.S.A. 100: 9319-9323.
130. Tanida Y, Ito MS, Fujitani H. 2007. Calculation of absolute free energy of binding for theophylline and its analogs to RNA aptamer using nonequilibrium work values. Chem. Phys. 337: 135-143.
131. Temiz NA, Bahar I. 2002. Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase. Proteins 49: 61-70.
132. Thomas JR, Hergenrother PJ. 2008. Targeting RNA with small molecules. Chem. Rev. 108: 1171-1224.
133. Tor Y. 2006. The ribosomal A-site as an inspiration for the design of RNA binders. Biochimie 88: 1045-1051.
134. Tozzini V. 2005. Coarse-grained models for proteins. Curr. Opin. Struct. Biol. 15: 144-150.
135. Trylska J, Tozzini V, McCammon JA. 2005. Exploring global motions and correlations in the ribosome. Biophys. J. 89: 1455-1463.
136. Vaiana AC, Westhof E, Auffinger P. 2006. A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns. Biochimie 88: 1061-1073.
137. Van Wynsberghe AW, Cui Q. 2005. Comparison of mode analyses at different resolutions applied to nucleic acid systems. Biophys. J. 89: 2939-2949.
138. Velec HF, Gohlke H, Klebe G. 2005. DrugScore(CSD)-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction. J. Med. Chem. 48: 6296-6303.
139. Vicens Q, Westhof E. 2003. RNA as a drug target: the case of aminoglycosides. ChemBioChem 4: 1018-1023.
140. Wallace ST, Schroeder R. 2000. In vitro selection and characterization of RNAs with high affinity to antibiotics. Methods Enzymol. 318: 214-229.
141. Wang Y, Rader AJ, Bahar I, Jernigan R. 2004. Global ribosome motions revealed with elastic network model. J. Struct. Biol. 147: 302-314.
142. Warshel A, Kato M, Pisliakov AV. 2007. Polarizable force fields: history, test cases, and prospects. J. Chem. Theor. Comput. 3: 2034-2045.
143. Warwicker J, Watson HC. 1982. Calculation of the electric-potential in the active-site cleft due to alpha-helix dipoles. J. Mol. Biol. 157: 671-679.
144. Wells S, Menor S, Hespenheide B, Thorpe MF. 2005. Constrained geometric simulation of diffusive motion in proteins. Phys. Biol. 2: 127-136.
145. Westhof E, Dumas P, Moras D. 1988. Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RNA crystals. Acta. Crystallogr. A 44 (Pt 2): 112-123.
146. Wilson DN, Schluenzen F, Harms JM, Starosta AL, Connell SR, Fucini P. 2008. The oxazolidinone antibiotics perturb the ribosomal peptidyltransferase center and effect tRNA positioning. Proc. Natl Acad. Sci. U.S.A. 105: 13339-13344.
147. Yang G, Trylska J, Tor Y, McCammon JA. 2006a. Binding of aminoglycosidic antibiotics to the oligonucleotide A-site model and 30S ribosomal subunit: Poisson-Boltzmann model, thermal denaturation, and fluorescence studies. J. Med. Chem. 49: 5478-5490.
148. Yang LW, Rader AJ, Liu X, Jursa CJ, Chen SC, Karimi HA, Bahar I. 2006b. oGNM: online computation of structural dynamics using the Gaussian network model. Nucleic Acids Res. 34: W24-W31.
149. Yoshizawa S, Fourmy D, Puglisi JD. 1998. Structural origins of gentamicin antibiotic action. EMBO J. 17: 6437-6448.
150. Zacharias M. 2000. Comparison of molecular dynamics and harmonic mode calculations on RNA. Biopolymers 54: 547-560.
151. Zacharias M. 2003. Perspectives of drug design that targets RNA. Curr. Med. Chem.: Anti-Infect. Agents 2: 161-172.
152. Zacharias M, Sklenar H. 2000. Conformational deformability of RNA: a harmonic mode analysis. Biophys. J. 78: 2528-2542.
153. Zavodszky MI, Ming L, Thorpe MF, Day AR, Kuhn LA. 2004. Modeling correlated main-chain motions in proteins for flexible molecular recognition. Proteins 57: 243-261.
154. Zhang Q, Sun X, Watt ED. Al-Hashimi HM. 2006. Resolving the motional modes that code for RNA adaptation. Science 311: 653-656.
155. Zhang Q, Stelzer A, Fisher C, Al-Hashimi H. 2007. Visualizing spatially correlated dynamics that directs RNA conformational transitions. Nature 450: 1263-1267.
156. Zhao XY, Liu XF, Wang YY, Chen Z, Kang L, Zhang HL, Luo XM, Zhu WL, Chen KX, Li HL, Wang XC, Jiang HL. 2008. An improved PMF scoring function for universally predicting the interactions of a ligand with protein, DNA, and RNA. J. Chem. Inf. Mod. 48: 1438-1447.
157. Zheng W. 2008. A unification of the elastic network model and the Gaussian network model for optimal description of protein conformational motions and fluctuations. Biophys. J. 94: 3853-3857.
158. Zou XQ, Sun YX, Kuntz ID. 1999. Inclusion of solvation in ligand binding free energy calculations using the generalized-born model. J. Am. Chem. Soc. 121: 8033-8043.